Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recovery

Experimental Cell Research

Volumn 315, Issue 15, 2009, Pages 2624-2636

  Gang, Eun Ji ^a   Darabi, Radbod ^a,c   Bosnakovski, Darko ^a,c   Xu, Zhaohui ^a   Kamm, Kristine E ^b   Kyba, Michael ^a,c   Perlingeiro, Rita C R ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Dystrophin; Mesenchymal stem cells; Muscle differentiation; Pax3; Transplantation; Tumors

Indexed keywords

DYSTROPHIN; TRANSCRIPTION FACTOR PAX3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; ENGRAFTMENT; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; MUSCLE CONTRACTILITY; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SKELETAL MUSCLE; THERAPY EFFECT;

MURINAE; MUS;

EID: 67651089683     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.05.009     Document Type: Article

References (63)

1. Hoffman E.P., Brown R.H.J., and Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51 (1987) 919-928
2. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., and Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50 (1987) 509-517
3. Nawrotzki R., Blake D.J., and Davies K.E. The genetic basis of neuromuscular disorders. Trends Genet. 12 (1996) 294-298
4. Petersen B.E., Bowen W.C., Patrene K.D., Mars W.M., Sullivan A.K., Murase N., Boggs S.S., Greenberger J.S., and Goff J.P. Bone marrow as a potential source of hepatic oval cells. Science 284 (1999) 1168-1170
5. Brazelton T.R., Rossi F.M., Keshet G.I., and Blau H.M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290 (2000) 1775-1779
6. Ito T., Suzuki A., Okabe M., Imai E., and Hori M. Application of bone marrow-derived stem cells in experimental nephrology. Exp. Nephrol. 9 (2001) 444-450
7. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Pickel J., McKay R., Nadal-Ginard B., Bodine D.M., Leri A., and Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
8. Lagasse E., Connors H., Al-Dhalimy M., Reitsma M., Dohse M., Osborne L., Wang X., Finegold M., Weissman I.L., and Grompe M. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 11 (2000) 1229-1234
9. Hess D., Li L., Martin M., Sakano S., Hill D., Strutt B., Thyssen S., Gray D.A., and Bhatia M. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol. 21 (2003) 763-770
10. Ferrari G., Cusella-De Angelis G., Coletta M., Paolucci E., Stornaiuolo A., Cossu G., and Mavilio F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279 (1998) 1528-1530
11. Gussoni E., Soneoka Y., Strickland C.D., Buzney E.A., Khan M.K., Flint A.F., Kunkel L.M., and Mulligan R.C. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401 (1999) 390-394
12. Bittner R.E., Schofer C., Weipoltshammer K., Ivanova S., Streubel B., Hauser E., Freilinger M., Hoger H., Elbe-Burger A., and Wachtler F. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat. Embryol. (Berl). 199 (1999) 391-396
13. Fukada S., Miyagoe-Suzuki Y., Tsukihara H., Yuasa K., Higuchi S., Ono S., Tsujikawa K., Takeda S., and Yamamoto H. Muscle regeneration by reconstitution with bone marrow or fetal liver cells from green fluorescent protein-gene transgenic mice. J. Cell Sci. 115 (2002) 1285-1293
14. Abedi M., Greer D.A., Foster B.M., Colvin G.A., Harpel J.A., Demers D.A., Pimentel J., Dooner M.S., and Quesenberry P.J. Critical variables in the conversion of marrow cells to skeletal muscle. Blood 106 (2005) 1488-1494
15. Bossolasco P., Corti S., Strazzer S., Borsotti C., Del Bo R., Fortunato F., Salani S., Quirici N., Bertolini F., Gobbi A., Deliliers G.L., Pietro Comi G., and Soligo D. Skeletal muscle differentiation potential of human adult bone marrow cells. Exp. Cell Res. 295 (2004) 66-78
16. Ferrari G., Stornaiuolo A., and Mavilio F. Failure to correct murine muscular dystrophy. Nature 411 (2001) 1014-1015
17. Alvarez-Dolado M., Pardal R., Garcia-Verdugo J.M., Fike J.R., Lee H.O., Pfeffer K., Lois C., Morrison S.J., and Alvarez-Buylla A. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425 (2003) 968-973
18. Castro R.F., Jackson K.A., Goodell M.A., Robertson C.S., Liu H., and Shine H.D. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science 297 (2002) 1299
19. Nygren J.M., Jovinge S., Breitbach M., Säwén P., Röll W., Hescheler J., Taneera J., Fleischmann B.K., and Jacobsen S.E. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10 (2004) 494-501
20. Wang X., Willenbring H., Akkari Y., Torimaru Y., Foster M., Al-Dhalimy M., Lagasse E., Finegold M., Olson S., and Grompe M. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422 (2003) 897-901
21. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., and Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 (2004) 668-673
22. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., Pasumarthi K.B., Virag J.I., Bartelmez S.H., Poppa V., Bradford G., Dowell J.D., Williams D.A., and Field L.J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
23. Pereira R.F., Halford K.W., O'Hara M.D., Leeper D.B., Sokolov B.P., Pollard M.D., Bagasra O., and Prockop D.J. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 4857-4861
24. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
25. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
26. Wakitani S.T., Caplan S., and A.I., Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18 (1995) 1417-1426
27. Saito T., Dennis J.E., Lennon D.P., Young R.G., and Caplan A.I. Myogenic expression of mesenchymal stem cells within myotubes of mdx mice in vitro and in vivo. Tissue Eng. 1 (1995) 327-343
28. Chan J., O'Donoghue K., Gavina M., Torrente Y., Kennea N., Mehmet H., Stewart H., Watt D.J., Morgan J.E., and Fisk N.M. Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells 24 (2006) 1879-1891
29. Dezawa M., Ishikawa H., Itokazu Y., Yoshihara T., Hoshino M., Takeda S., Ide C., and Nabeshima Y. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309 (2005) 314-317
30. Gang E.J., Bosnakovski D., Simsek T., To K., and Perlingeiro R.C.R. Pax3 activation promotes the differentiation of mesenchymal stem cells toward the myogenic lineage. Exp. Cell Res. (2008) doi:10.1016/j.yexcr.2008.02.016
31. Kyba M., Perlingeiro R.C., and Daley G.Q. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109 (2002) 29-37
32. Lois C., Hong E.J., Pease S., Brown E.J., and Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295 (2002) 868-872
33. Wijker M., Morgan N.V., Herterich S., van Berkel C.G., Tipping A.J., Gross H.J., Gille J.J., Pals G., Savino M., Altay C., Mohan S., Dokal I., Cavenagh J., Marsh J., van Weel M., Ortega J.J., Schuler D., Samochatova E., Karwacki M., Bekassy A.N., Abecasis M., Ebell W., Kwee M.L., de Ravel T., and Mathew C.G. Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur. J. Hum. Genet. 7 (1999) 52-59
34. Khan J., Simon R., Bittner M., Chen Y., Leighton S.B., Pohida T., Smith P.D., Jiang Y., Gooden G.C., Trent J.M., and Meltzer P.S. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 58 (1998) 5009-5013
35. Sebire N.J., and Malone M. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. J. Clin. Pathol. 56 (2003) 412-416
36. Keller C., Arenkiel B.R., Coffin C.M., El-Bardeesy N., DePinho R.A., and Capecchi M.R. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev. 18 (2004) 2614-2626
37. Galili N., Davis R.J., Fredericks W.J., Mukhopadhyay S., Rauscher F.J.r., Emanuel B.S., Rovera G., and Barr F.G. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 5 (1993) 230-235
38. Davis R.J., D'Cruz C.M., Lovell M.A., Biegel J.A., and Barr F.G. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res. 54 (1994) 2869-2872
39. Gang E.J., Bosnakovski D., Figueiredo C.A., Visser J.W., and Perlingeiro R.C.R. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109 (2007) 1743-1751
40. Megeney L.A., Kablar B., Garrett K., Anderson J.E., and Rudnicki M.A. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 10 (1996) 1173-1183
41. Montarras D., Morgan J., Collins C., Relaix F., Zaffran S., Cumano A., Partridge T., and Buckingham M. Direct isolation of satellite cells for skeletal muscle regeneration. Science 309 (2005) 2064-2067
42. Sherwood R.I., Christensen J.L., Conboy I.M., Conboy M.J., Rando T.A., Weissman I.L., and Wagers A.J. Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell 119 (2004) 543-554
43. Qu-Petersen Z., Deasy B., Jankowski R., Ikezawa M., Cummins J., Pruchnic R., Mytinger J., Cao B., Gates C., Wernig A., and Huard J. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J. Cell Biol. 157 (2002) 851-864
44. Sampaolesi M., Torrente Y., Innocenzi A., Tonlorenzi R., D'Antona G., Pellegrino M.A., Barresi R., Bresolin N., De Angelis M.G., Campbell K.P., Bottinelli R., and Cossu G. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301 (2003) 487-492
45. Cerletti M., Jurga S., Witczak C.A., Hirshman M.F., Shadrach J.L., Goodyear L.J., and Wagers A.J. Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell 134 (2008) 37-47
46. Vieira N.M., Bueno C.R.J., Brandalise V., Moraes L.V., Zucconi E., Secco M., Suzuki M.F., Camargo M.M., Bartolini P., Brum P.C., Vainzof M., and Zatz M. Sjl dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression. Stem Cells (2008) [electronic publication ahead of print]
47. Rodriguez A.M., Pisani D., Dechesne C.A., Turc-Carel C., Kurzenne J.Y., Wdziekonski B., Villageois A., Bagnis C., Breittmayer J.P., Groux H., Ailhaud G., and Dani C. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J. Exp. Med. 201 (2005) 1397-1405
48. Torrente Y., Belicchi M., Sampaolesi M., Pisati F., Meregalli M., D'Antona G., Tonlorenzi R., Porretti L., Gavina M., Mamchaoui K., Pellegrino M.A., Furling D., Mouly V., Butler-Browne G.S., Bottinelli R., Cossu G., and Bresolin N. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J. Clin. Invest. 114 (2004) 182-195
49. Kopan R., Nye J.S., and Weintraub H. The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. Development 120 (1994) 2385-2396
50. Wilson-Rawls J., Molkentin J.D., Black B.L., and Olson E.N. Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C. Mol. Cell. Biol. 19 (1999) 2853-2862
51. Nofziger D., Miyamoto A., Lyons K.M., and Weinmaster G. Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development 126 (1999) 1689-1702
52. Kitamura T., Kitamura Y.I., Funahashi Y., Shawber C.J., Castrillon D.H., Kollipara R., DePinho R.A., Kitajewski J., and Accili D. A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J. Clin. Invest. 117 (2007) 2477-2485
53. Kassar-Duchossoy L., Giacone E., Gayraud-Morel B., Jory A., Gomes D., and Tajbakhsh S. Pax3/Pax7 mark a novel population of primitive myogenic cells during development. Genes Dev. 19 (2005) 1426-1431
54. Relaix F., Rocancourt D., Mansouri A., and Buckingham M. A Pax3/Pax7-dependent population of skeletal muscle progenitor cells. Nature 435 (2005) 948-953
55. Goulding M., Lumsden A., and Paquette A.J. Regulation of Pax-3 expression in the dermomyotome and its role in muscle development. Development 120 (1994) 957-971
56. Tremblay J.P., Dietrich S., Mericskay M., Scubert F.R., Li Z., and Paulin D. A crucial role for Pax3 in the development of the hypaxial musculature and the long-range migration of muscle precursors. Dev. Biol. 203 (1998) 49-61
57. Darabi R., Gehlbach K., Bachoo R.M., Kamath S., Osawa M., Kamm K.E., Kyba M., and Perlingeiro R.C. Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat. Med. 14 (2008) 134-143
58. Barr F.G., Galili N., Holick J., Biegel J.A., Rovera G., and Emanuel B.S. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 3 (1993) 113-117
59. Sorensen P.H., Lynch J.C., Qualman S.J., Tirabosco R., Lim J.F., Maurer H.M., Bridge J.A., Crist W.M., Triche T.J., and Barr F.G. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J. Clin. Oncol. 20 (2002) 2672-2679
60. Lagutina I., Conway S.J., Sublett J., and Grosveld G.C. Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors. Mol. Cell. Biol. 22 (2002) 7204-7216
61. Finckenstein F.G., Davicioni E., Osborn K.G., Cavenee W.K., Arden K.C., and Anderson M.J. Transgenic mice expressing PAX3-FKHR have multiple defects in muscle development, including ectopic skeletal myogenesis in the developing neural tube. Transgenic Res. 15 (2006) 595-614
62. Dellavalle A., Sampaolesi M., Tonlorenzi R., Tagliafico E., Sacchetti B., Perani L., Innocenzi A., Galvez B.G., Messina G., Morosetti R., Li S., Belicchi M., Peretti G., Chamberlain J.S., Wright W.E., Torrente Y., Ferrari S., Bianco P., and Cossu G. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat. Cell Biol. 9 (2007) 255-267
63. Rose R.A., Jiang H., Wang X., Helke S., Tsoporis J.N., Gong N., Keating S.C., Parker T.G., Backx P.H., and Keating A. Bone marrow-derived mesenchymal stromal cells express cardiac- specific markers, retain the stromal phenotype and do not become functional cardiomyocytes in vitro. Stem Cells 26 (2008) 2884-2892